Cardium Therapeutics, Inc.

EDGAR

Market value is not computed: no recent price is available.

109 filing records in this dataset, filed from 1996-05-15 to 2022-04-14. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

0 USD

2014 Q3 · USD

Exact inputs and evidence

Operating cash flow

-722 thousand USD

2014 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -2433134 USD Source
  • Operating Cash Flow: -1711412 USD Source

Free cash flow

-722 thousand USD

2014 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -2433134 USD Source
  • Operating Cash Flow: -1711412 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
386 thousand USD Source
Exact value

386027 USD

Long-term debt including current maturities
Not available
Shares outstanding
40.3 million shares Source
Exact value

40330117 shares

Reported share-count change

178.34% · 25.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 14489399 shares · 2019-12-31· Source
  • 40330117 shares · 2020-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2013-10-01 – 2014-09-30

Exact inputs and evidence
  • Revenue: 109200 USD · 2013-01-01 – 2013-12-31 Source
  • Revenue: 109200 USD · 2013-01-01 – 2013-09-30 Source
  • Revenue: 0 USD · 2014-01-01 – 2014-03-31 Source
  • Revenue: 0 USD · 2014-04-01 – 2014-06-30 Source
  • Revenue: 0 USD · 2014-07-01 – 2014-09-30 Source

Net income

-518 thousand USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Net income: -149763 USD · 2020-01-01 – 2020-03-31 Source
  • Net income: 435787 USD · 2020-04-01 – 2020-06-30 Source
  • Net income: -361132 USD · 2020-07-01 – 2020-09-30 Source
  • Net income: -517897 USD · 2020-01-01 – 2020-12-31 Source
  • Net income: -75109 USD · 2020-01-01 – 2020-09-30 Source

Operating cash flow

-1.13 million USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Operating cash flow: -93857 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -315341 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -93857 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -795140 USD · 2020-01-01 – 2020-09-30 Source
  • Operating cash flow: -315341 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -1133005 USD · 2020-01-01 – 2020-12-31 Source
  • Operating cash flow: -795140 USD · 2020-01-01 – 2020-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2022-04-14.

Financial data available through: 2020-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2013-12-31
  • Operating income: 11 of 11 periods available· newest 2020-12-31
  • Net income: 11 of 11 periods available· newest 2020-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2020-12-31
  • Capital expenditure: 6 of 11 periods available· newest 2020-12-31
  • Total assets: 11 of 11 periods available· newest 2020-12-31
  • Total liabilities: 11 of 11 periods available· newest 2020-12-31
  • Current assets: 11 of 11 periods available· newest 2020-12-31
  • Current liabilities: 11 of 11 periods available· newest 2020-12-31
  • Cash and cash equivalents: 9 of 11 periods available· newest 2020-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 11 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    -159.8%

    Prior period

    USD 866,675

    –

    Current period

    −USD 517,897

    –

    Exact inputs and evidence

    -517897 − 866675 = -1384572 USD

    866675 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -517897 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 995,843

    Prior period

    −USD 137,162

    –

    Current period

    −USD 1.13 million

    –

    Exact inputs and evidence

    -1133005 − -137162 = -995843 USD

    -137162 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -1133005 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

  • Revenue USD 109,200 100% of revenue
  • Cost of revenue USD 69,160 63% of revenue
  • Operating expenses USD 6.95 million 6,361% of revenue
  • Operating income −USD 6.91 million −6,324% of revenue
  • Tax, interest and other Derived USD 2.01 million 1,839% of revenue
  • Net income −USD 8.91 million −8,163% of revenue

Cash

  • Operating cash flow USD 6 million 5,495% of revenue
  • Capital expenditure USD 23,053 21% of revenue
  • Free cash flow Derived USD 5.98 million 5,473% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2011 Not shown: operating income or net income is not reported.
  • 2012 Operating loss: operating costs were 14,061% of revenue.
  • 2013 Operating loss: operating costs were 6,424% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2011 2011-01-01 – 2011-12-310 7417917 Derived -7417917 -288825 Derived -7129092 -7677904 Derived
Source
2012 2012-01-01 – 2012-12-3159409 8353230 Derived -8293821 29489 Derived -8323310 -9228431 Derived
Source
2013 2013-01-01 – 2013-12-31109200 7015449 Derived -6906249 2008044 Derived -8914293 5976947 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 109.2K 2013
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.117.9K88.5K59.0K29.5K0.0201120122013
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Revenue0
2012Revenue59409
2013Revenue109200

Revenue growth

Change in revenue from the same financial period one year earlier.

83.8% 2013
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.91%68%45%23%0%201120122013
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2011Year over yearNo prior comparable period
2012Year over yearNo prior comparable period
2013Year over year83.8%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,324.4% 2013
Net margin -8,163.3% 2013
Free cash flow margin 5,473.4% 2013
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7,154%1,062%-5,030%-11,122%-17,214%201120122013
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2011Operating marginNot reported
2012Operating margin-13,960.5%
2013Operating margin-6,324.4%
2011Net marginNot reported
2012Net margin-14,010.2%
2013Net margin-8,163.3%
2011Free cash flow marginNot reported
2012Free cash flow margin-15,533.7%
2013Free cash flow margin5,473.4%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 6M 2013
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.2M2.8M-1.6M-6.0M-10.4M201120122013
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Operating cash flow-7673496
2012Operating cash flow-9212565
2013Operating cash flow6000000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 6M 2013
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.2M2.8M-1.6M-6.0M-10.4M201120122013
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Free cash flow-7677904
2012Free cash flow-9228431
2013Free cash flow5976947

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

57.5% 2013
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.62%47%31%16%0%201120122013
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2011Liabilities / assets18.9%
2012Liabilities / assets18.5%
2013Liabilities / assets57.5%

Current assets to current liabilities

Current assets divided by current liabilities.

0.31× 2013
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.46×3.35×2.23×1.12×0.00×201120122013
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2011Current assets / current liabilities4.13×
2012Current assets / current liabilities3.08×
2013Current assets / current liabilities0.31×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2011 2011-01-01 – 2011-12-31
−USD 7.13 million
Exact value

Exact value: -7129092 USD

2011-01-01 – 2011-12-31: -7129092 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.67 million
Exact value

Exact value: -7673496 USD

2011-01-01 – 2011-12-31: -7673496 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4,408
Exact value

Exact value: 4408 USD

2011-01-01 – 2011-12-31: 4408 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.68 million
Calculation and evidence

-7673496 − 4408 USD

Exact free cash flow: -7677904 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2012 2012-01-01 – 2012-12-31
−USD 8.32 million
Exact value

Exact value: -8323310 USD

2012-01-01 – 2012-12-31: -8323310 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.21 million
Exact value

Exact value: -9212565 USD

2012-01-01 – 2012-12-31: -9212565 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 15,866
Exact value

Exact value: 15866 USD

2012-01-01 – 2012-12-31: 15866 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.23 million
Calculation and evidence

-9212565 − 15866 USD

Exact free cash flow: -9228431 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2013 2013-01-01 – 2013-12-31
−USD 8.91 million
Exact value

Exact value: -8914293 USD

2013-01-01 – 2013-12-31: -8914293 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6 million
Exact value

Exact value: 6000000 USD

2013-01-01 – 2013-12-31: 6000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 23,053
Exact value

Exact value: 23053 USD

2013-01-01 – 2013-12-31: 23053 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5.98 million
Calculation and evidence

6000000 − 23053 USD

Exact free cash flow: 5976947 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2014 2014-01-01 – 2014-12-31
−USD 5.51 million
Exact value

Exact value: -5505536 USD

2014-01-01 – 2014-12-31: -5505536 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.62 million
Exact value

Exact value: -2624113 USD

2014-01-01 – 2014-12-31: -2624113 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2015 2015-01-01 – 2015-12-31
−USD 3.7 million
Exact value

Exact value: -3697560 USD

2015-01-01 – 2015-12-31: -3697560 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.05 million
Exact value

Exact value: -1052895 USD

2015-01-01 – 2015-12-31: -1052895 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2016 2016-01-01 – 2016-12-31
−USD 2.92 million
Exact value

Exact value: -2918228 USD

2016-01-01 – 2016-12-31: -2918228 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.02 million
Exact value

Exact value: -2023607 USD

2016-01-01 – 2016-12-31: -2023607 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 171,728
Exact value

Exact value: 171728 USD

2016-01-01 – 2016-12-31: 171728 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.2 million
Calculation and evidence

-2023607 − 171728 USD

Exact free cash flow: -2195335 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 1.89 million
Exact value

Exact value: -1894142 USD

2017-01-01 – 2017-12-31: -1894142 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.06 million
Exact value

Exact value: -1062388 USD

2017-01-01 – 2017-12-31: -1062388 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
−USD 434,881
Exact value

Exact value: -434881 USD

2018-01-01 – 2018-12-31: -434881 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 451,503
Exact value

Exact value: -451503 USD

2018-01-01 – 2018-12-31: -451503 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2019 2019-01-01 – 2019-12-31
USD 866,675
Exact value

Exact value: 866675 USD

2019-01-01 – 2019-12-31: 866675 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 137,162
Exact value

Exact value: -137162 USD

2019-01-01 – 2019-12-31: -137162 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−USD 517,897
Exact value

Exact value: -517897 USD

2020-01-01 – 2020-12-31: -517897 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.13 million
Exact value

Exact value: -1133005 USD

2020-01-01 – 2020-12-31: -1133005 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3,433
Exact value

Exact value: 3433 USD

2020-01-01 – 2020-12-31: 3433 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.14 million
Calculation and evidence

-1133005 − 3433 USD

Exact free cash flow: -1136438 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

109 filings · 2,058 latest values · 2,058 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000772320, 772320, CRXM, edgar:772320

Also known as ARIES VENTURES INC, CASMYN CORP, Cardium Therapeutics, Inc., Gene Biotherapeutics, Inc., Taxus Cardium Pharmaceuticals Group Inc.